MentalHealthCE Login
Not registered? Create an account now or when you purchase, to maintain a CE history.
| Login |
Healthcare Training Institute - Quality Education since 1979
CE for Psychologist, Social Worker, Counselor, & MFT!!
HIV/AIDS - Recent Articles
Dissent on doxyPEP: recent guidelines becoming more cautious
Two recent statements about taking the antibiotic doxycycline up to 72 hours after sex to prevent bacterial sexually transmitted infections, a prevention intervention known as doxyPEP, are notably more cautious about recommending its use than the first guidelines from California.
Two recent statements about taking the antibiotic doxycycline up to 72 hours after sex to prevent bacterial sexually transmitted infections, a prevention intervention known as doxyPEP, are notably more cautious about recommending its use than the first guidelines from California.
Relationship skills can reduce the risk of HIV in young male couples
An online HIV prevention and relationship education programme developed by Dr Michael Newcomb and colleagues from Northwestern University is proving effective in reducing the risk of HIV in young male couples in the United States, a group disproportionately affected by HIV.
An online HIV prevention and relationship education programme developed by Dr Michael Newcomb and colleagues from Northwestern University is proving effective in reducing the risk of HIV in young male couples in the United States, a group disproportionately affected by HIV.
Switching from TAF to TDF leads to weight loss
Switching from tenofovir alafenamide (TAF) to the older formulation of tenofovir disoproxil (TDF) resulted in modest weight loss in people with HIV in the Swiss HIV Cohort, researchers report in the journal Clinical Infectious Diseases. Switching from TAF to TDF also brought benefits in the forms of reduced cholesterol and triglycerides. In contrast, switching from TAF-containing treatment to a two-drug combination of dolutegravir/lamivudine or injectable cabotegravir/rilpivirine did not lead to any changes in weight.
Switching from tenofovir alafenamide (TAF) to the older formulation of tenofovir disoproxil (TDF) resulted in modest weight loss in people with HIV in the Swiss HIV Cohort, researchers report in the journal Clinical Infectious Diseases. Switching from TAF to TDF also brought benefits in the forms of reduced cholesterol and triglycerides. In contrast, switching from TAF-containing treatment to a two-drug combination of dolutegravir/lamivudine or injectable cabotegravir/rilpivirine did not lead to any changes in weight.
Danish study finds that STI rates in gay men increase before they start PrEP, not after
A Danish study which was able to chart the annual incidence of the three bacterial STIs, chlamydia, gonorrhoea and syphilis, in people attending sexual health clinics both before and after they started PrEP has found that they had more than twice as many (115% more) STI diagnoses while on PrEP than they had some time before starting it.
A Danish study which was able to chart the annual incidence of the three bacterial STIs, chlamydia, gonorrhoea and syphilis, in people attending sexual health clinics both before and after they started PrEP has found that they had more than twice as many (115% more) STI diagnoses while on PrEP than they had some time before starting it.
Cryptococcal meningitis persists in Botswana, despite high antiretroviral coverage
A study of cryptococcal meningitis incidence in people with HIV in Botswana shows that incidence has halved since 2015 and that the decline is correlated to increased antiretroviral coverage. But the study found that men were more likely to be diagnosed with cryptococcal meningitis than women and that illness related to advanced HIV remains a substantial problem despite achieving near-universal treatment coverage.
A study of cryptococcal meningitis incidence in people with HIV in Botswana shows that incidence has halved since 2015 and that the decline is correlated to increased antiretroviral coverage. But the study found that men were more likely to be diagnosed with cryptococcal meningitis than women and that illness related to advanced HIV remains a substantial problem despite achieving near-universal treatment coverage.
More evidence that PrEP works as well for women
In a presentation at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2024), the case was made that event-driven pre-exposure prophylaxis (PrEP) might work just as well for women as men, and should be offered to them as an option.
In a presentation at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2024), the case was made that event-driven pre-exposure prophylaxis (PrEP) might work just as well for women as men, and should be offered to them as an option.
Adolescent mothers with HIV in South Africa have poorer HIV outcomes than non-mothers, study finds
Adolescent girls who are mothers and living with HIV, experience more interruptions in their antiretroviral (ART) treatment, have poorer adherence, poorer clinical attendance and lower viral suppression rates compared to those who are not mothers, a recent study published in the Journal of the International AIDS Society found.
Adolescent girls who are mothers and living with HIV, experience more interruptions in their antiretroviral (ART) treatment, have poorer adherence, poorer clinical attendance and lower viral suppression rates compared to those who are not mothers, a recent study published in the Journal of the International AIDS Society found.
Growing racial and gender PrEP inequities in England, despite increased access
The proportion of Black African women diagnosed with HIV increased between 2017 and 2021 in England, while the proportion of new diagnoses among White men dropped by 20%. Over this period, the proportion of PrEP users who were women, including Black African women, fell. Thus, when comparing Black African women to White men, and women to men, PrEP inequities have increased substantially, despite wider PrEP accessibility.
The proportion of Black African women diagnosed with HIV increased between 2017 and 2021 in England, while the proportion of new diagnoses among White men dropped by 20%. Over this period, the proportion of PrEP users who were women, including Black African women, fell. Thus, when comparing Black African women to White men, and women to men, PrEP inequities have increased substantially, despite wider PrEP accessibility.
Zimbabwe: low-cost, brief psychological intervention helps people with HIV stay virally suppressed
Results from a study published in PLOS Global Public Health show that people with HIV and common mental disorders in Zimbabwe can benefit from a low-cost and brief psychological intervention called the Friendship Bench to improve their mental health outcomes and, consequently, sustain viral suppression on antiretroviral therapy.
Results from a study published in PLOS Global Public Health show that people with HIV and common mental disorders in Zimbabwe can benefit from a low-cost and brief psychological intervention called the Friendship Bench to improve their mental health outcomes and, consequently, sustain viral suppression on antiretroviral therapy.
To breastfeed or not: mothers living with HIV in African countries still unclear on what to do
New mothers living with HIV are often unsure about whether or not to breastfeed their children, and for how long, the African Workshop on HIV & Women held in Nairobi, Kenya in February heard. This is because their infant feeding practices are influenced by the people around them, which makes the decision-making process even more difficult.
New mothers living with HIV are often unsure about whether or not to breastfeed their children, and for how long, the African Workshop on HIV & Women held in Nairobi, Kenya in February heard. This is because their infant feeding practices are influenced by the people around them, which makes the decision-making process even more difficult.
HIV clinicians in Spain underestimate their patients’ HIV-related symptoms
Despite advances in HIV care and treatment, a study has found a large proportion of people with HIV still experience symptoms that are underestimated or unacknowledged by their HIV doctors. Dr José Galindo Puerto of the Spanish AIDS Interdisciplinary Society (SEISIDA) and colleagues found discrepancies between the frequency and burdens of HIV and HIV treatment symptoms reported by Spaniards living with HIV and the HIV specialists caring for them. Their results highlight a need for better communication between clinicians and patients.
Despite advances in HIV care and treatment, a study has found a large proportion of people with HIV still experience symptoms that are underestimated or unacknowledged by their HIV doctors. Dr José Galindo Puerto of the Spanish AIDS Interdisciplinary Society (SEISIDA) and colleagues found discrepancies between the frequency and burdens of HIV and HIV treatment symptoms reported by Spaniards living with HIV and the HIV specialists caring for them. Their results highlight a need for better communication between clinicians and patients.
Big falls in HIV deaths in high-income countries – except for injecting drug users
While there have been reductions in the rates of most major causes of death among people with HIV in North America and Europe since 1996, people who inject drugs – particularly women – remain vulnerable to early death. Background Before 1996 – when combination antiretroviral therapy (ART) became the mainstay of HIV treatment – death from AIDS was a near inevitability, even in high-income countries. Due to ART’s high effectiveness at suppressing HIV, AIDS-related deaths have declined steeply, particularly in Europe and North America. [GLOSSARY]
While there have been reductions in the rates of most major causes of death among people with HIV in North America and Europe since 1996, people who inject drugs – particularly women – remain vulnerable to early death. Background Before 1996 – when combination antiretroviral therapy (ART) became the mainstay of HIV treatment – death from AIDS was a near inevitability, even in high-income countries. Due to ART’s high effectiveness at suppressing HIV, AIDS-related deaths have declined steeply, particularly in Europe and North America. [GLOSSARY]
Nigerian analysis defines what makes a youth-friendly HIV service work
A recent study identifies the factors which contribute to the effective delivery of youth-friendly services, so as to achieve better outcomes for adolescents. Globally, around five million adolescents (aged 15-24) are living with HIV. There is consensus that youth-friendly approaches to delivering care do support better health outcomes. However, there are gaps in knowledge about how they work in practice. This analysis explored whether specific mechanisms could influence outcomes.
A recent study identifies the factors which contribute to the effective delivery of youth-friendly services, so as to achieve better outcomes for adolescents. Globally, around five million adolescents (aged 15-24) are living with HIV. There is consensus that youth-friendly approaches to delivering care do support better health outcomes. However, there are gaps in knowledge about how they work in practice. This analysis explored whether specific mechanisms could influence outcomes.
Why is the roll-out of injectable PrEP taking so long?
A symposium at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) earlier this month included presentations advocating changes in practice on what might be called opposite ends of the menu of PrEP options now on offer.
A symposium at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) earlier this month included presentations advocating changes in practice on what might be called opposite ends of the menu of PrEP options now on offer.
Weight gain on HIV treatment: more than a 'return to health' phenomenon?
Weight gain on antiretroviral treatment is not solely a ‘return to health’ effect, research presented earlier this month at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) suggests.
Weight gain on antiretroviral treatment is not solely a ‘return to health’ effect, research presented earlier this month at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) suggests.
The US opioid crisis has reached older people with HIV
People with HIV aged 65 and older were more likely to be prescribed opioids and be diagnosed with opioid use disorder than HIV-negative older adults in the US, according to data presented by Dr Stephanie Shiau to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver recently.
People with HIV aged 65 and older were more likely to be prescribed opioids and be diagnosed with opioid use disorder than HIV-negative older adults in the US, according to data presented by Dr Stephanie Shiau to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver recently.
Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds
How young people feel about long-acting injectable treatment remains largely unexplored. The More Options for Children and Adolescents (MOCHA) study provides some insight into the experiences of young people aged 12-18 who have switched to long-acting cabotegravir / rilpivirine based treatment. It is the first to examine use of long-acting injectable antiretrovirals in virally suppressed adolescents.
How young people feel about long-acting injectable treatment remains largely unexplored. The More Options for Children and Adolescents (MOCHA) study provides some insight into the experiences of young people aged 12-18 who have switched to long-acting cabotegravir / rilpivirine based treatment. It is the first to examine use of long-acting injectable antiretrovirals in virally suppressed adolescents.
Almost two-thirds of new HIV cases occur outside southern and eastern Africa
Almost two-thirds of new cases of HIV now occur outside countries with high HIV prevalence in southern and eastern Africa, according to an analysis of UNAIDS country-level data presented earlier this month at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver.
Almost two-thirds of new cases of HIV now occur outside countries with high HIV prevalence in southern and eastern Africa, according to an analysis of UNAIDS country-level data presented earlier this month at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver.
Top 5 stories on HIV in the US from CROI 2024
The Conference on Retroviruses and Opportunistic Infections (CROI 2024), took place earlier this month with research from around the world. Here is a roundup of research focused on the US.
The Conference on Retroviruses and Opportunistic Infections (CROI 2024), took place earlier this month with research from around the world. Here is a roundup of research focused on the US.
People who inject drugs in the US are more aware of PrEP, but aren’t taking it
While 1 in 3 people who inject drugs were aware of PrEP in 2022, only 1 in 100 actually took it. Despite changes in PrEP awareness between 2018 and 2022, increases in uptake for this vulnerable group were small, according to data presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) earlier this month in Denver by Dr Patrick Eustaquio.
Orders received after 10:00 AM E Monday will be mailed the following Monday from Florida.
While 1 in 3 people who inject drugs were aware of PrEP in 2022, only 1 in 100 actually took it. Despite changes in PrEP awareness between 2018 and 2022, increases in uptake for this vulnerable group were small, according to data presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) earlier this month in Denver by Dr Patrick Eustaquio.
Copyright © 2024 MentalHealthCE.com
X
Timing of Shipment of Orders:
Orders received before 10:00 AM E Monday are mailed via USPS that Monday from Florida.Orders received after 10:00 AM E Monday will be mailed the following Monday from Florida.